Search references for METYRAPONE. Phrases containing METYRAPONE
See searches and references containing METYRAPONE!METYRAPONE
Chemical compound
Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment
Metyrapone
Pharmaceutical compound
Metyrapone/oxazepam (developmental code name EMB-001) is a combination of metyrapone, an 11β-hydroxylase inhibitor (and cortisol synthesis inhibitor),
Metyrapone/oxazepam
Class of pharmaceutical drugs
receptor antagonists such as mifepristone and synthesis inhibitors such as metyrapone, ketoconazole, and aminoglutethimide. They are used to treat Cushing's
Antiglucocorticoid
Drug class
11β-Hydroxylase (CYP11B1) inhibitors such as amphenone B, etomidate, ketoconazole, metyrapone, mitotane, and osilodrostat inhibit the production of the potent corticosteroids
Steroidogenesis_inhibitor
Investigational substance-related disorder drugs
modulator/nonbenzodiazepine – substance-related disorders Metyrapone/oxazepam (EMB-001C; EMB-001) – combination of metyrapone (11β-hydroxylase inhibitor and cortisol synthesis
List of investigational substance-related disorder drugs
List_of_investigational_substance-related_disorder_drugs
Glucocorticoid and mineralocorticoid hormone Cortisol supplied as a medication
Antiglucocorticoids like corticotropin-releasing hormone antagonists, mifepristone, and metyrapone were extensively studied for treatment of depression, but were found to
Hydrocortisone
Medical diagnostic test
insufficiency, Congenital adrenal hyperplasia (21-hydroxylase, 3 beta) metyrapone panel metyrapone cortisol, 11-deoxycortisol adrenal insufficiency dexamethasone
Evocative/suppression_testing
Medication against high blood pressure
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Amlodipine
Glucocorticoid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Fluticasone_propionate
Pharmaceutical preparation
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical
Tobramycin/dexamethasone
Corticosteroid precursor and metabolite of cortisol
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Cortisone
Psychoactive component of cannabis
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Tetrahydrocannabinol
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Fenbendazole
Chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Eplerenone
Medication to treat gastroesophageal reflux disease and other conditions
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Omeprazole
Steroid acid in the bile of animals
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Bile_acid
(grapefruit) Gabapentin Isoniazid Ketoconazole Letrozole Methimazole Methoxsalen Metyrapone Miconazole Modafinil Nicotine Orphenadrine Pilocarpine Pregabalin Selegiline
List of cytochrome P450 modulators
List_of_cytochrome_P450_modulators
Medical condition
as the test using metyrapone or a test which employs insulin to induce hypoglycemia, are not preferred for CIRCI. Both a metyrapone-induced decrease in
Critical illness–related corticosteroid insufficiency
Critical_illness–related_corticosteroid_insufficiency
Antibiotic
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Clindamycin
Chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Finerenone
Lipid-lowering medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Simvastatin
Antibiotic
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Tetracycline
Symptoms from excessive exposure to glucocorticoids such as cortisol
drugs have been found to inhibit cortisol synthesis (e.g. ketoconazole, metyrapone) but they are of limited efficacy.[citation needed] Mifepristone is a
Cushing's_syndrome
Medication for skin
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical
Topical_steroid
Chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical
Osilodrostat
Investigational other psychiatric disorder drugs
(MAGL) inhibitor – psychiatric disorders [35] Metyrapone/oxazepam (EMB-001C; EMB-001) – combination of metyrapone (11β-hydroxylase inhibitor and cortisol synthesis
List of investigational other psychiatric disorder drugs
List_of_investigational_other_psychiatric_disorder_drugs
Corticosteroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Dexamethasone
Biochemical Molecule
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical
Hydroxycorticosteroids
Steroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Prednisone
metronidazole Metrolotion Metromidol metronidazole (INN) Metubine Iodide meturedepa (INN) metynodiol (INN) metyrapone (INN) metyridine (INN) metyrosine
List_of_drugs:_Met
Medical intervention
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical
Antenatal_steroid
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Colforsin_daropate
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Tolnaftate
Steroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Triamcinolone
Anticonvulsant medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Carbamazepine
Decreased output of hormones by the pituitary gland
test) can be performed to confirm the diagnosis. Stimulation testing with metyrapone is an alternative. Some suggest that an ACTH stimulation test is sufficient
Hypopituitarism
Antibiotic medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Erythromycin
Mosaic genetic disorder affecting the bone, skin and endocrine systems
in the first year of life. Adrenalectomy is the treatment of choice. Metyrapone may also be used for treatment. McCune–Albright syndrome is estimated
McCune–Albright_syndrome
Steroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Mometasone
Corticosteroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Prednisolone
Mechanisms of action
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Pharmacodynamics of spironolactone
Pharmacodynamics_of_spironolactone
Antibiotic derived from Penicillin
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Dicloxacillin
Insufficient production of steroid hormones by the adrenal glands
CMV, histoplasmosis Drugs: e.g. anticonvulsants, etomidate, Zytiga , metyrapone, rifampicin Vascular: e.g. hemorrhage from sepsis, adrenal vein thrombosis
Adrenal_insufficiency
pregnenolone has similarly been found to act as a prodrug of allopregnanolone. Metyrapone, a reversible inhibitor of the enzyme steroid 11β-hydroxylase, may increase
Neurosteroidogenesis inhibitor
Neurosteroidogenesis_inhibitor
Medication and supplement
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Pregnenolone_(medication)
Medication used as chemotherapy and to suppress the immune system
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Cyclophosphamide
Blood pressure medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Telmisartan
Tumor of the pituitary gland
is second line, and includes steroidogenesis inhibitors (ketoconazole, metyrapone, osilodrostat, etomidate or mitotane) which decrease production of cortisol
Pituitary_adenoma
Calcium channel blocker medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Nifedipine
Steroidal antiandrogen and antimineralocorticoid
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Spironolactone
Pharmaceutical drug
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Deflazacort
Chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Methylprednisolone_acetate
Antiarrhythmic medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Amiodarone
Medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Clobetasol_propionate
Alkaloid responsible for the pungency of black pepper
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Piperine
Opioid medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Fentanyl
Mammalian pheromone also found in truffles
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Androstenol
Steroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Betamethasone
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Terconazole
Chemical compound
the synthesis of the following: pirmenol, rivanicline, MTEP, preclamol, metyrapone, biricodar, etc. Li, Wenjie; Nelson, Dorian P.; Jensen, Mark S.; Hoerrner
3-Bromopyridine
Antiprogestogen and antiglucocorticoid drug
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Mifepristone
Antihistamine medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Loratadine
Medication and insecticide
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Permethrin
American endocrinologist (1921–1989)
dexamethasone suppression test for assessing adrenal function and the metyrapone test for pituitary reserve. He discovered a method for measuring aldosterone
Grant_Liddle
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Meclizine
Medical test to assess adrenal gland function
test, another test used to identify sub-types of adrenal insufficiency Metyrapone, a drug used in the diagnosis of adrenal insufficiency Triple bolus test
ACTH_stimulation_test
Pharmaceutical drug classification
V04CC02 Magnesium sulfate V04CC03 Sincalide V04CC04 Ceruletide V04CD01 Metyrapone V04CD03 Sermorelin V04CD04 Corticorelin V04CD05 Somatorelin V04CD06 Macimorelin
ATC_code_V04
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Cyproterone_acetate
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Clotrimazole
Chemical compound
and its analogues. ACTH stimulation test Dexamethasone suppression test Metyrapone Pituitary-adrenal axis Tetracosactide Andoh K, Kimura T, Saeki I, et al
Corticorelin
UK pharmaceutical company
H (2004). "Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone". Science. 305 (5684): 683–6. Bibcode:2004Sci...305.
Astex_Pharmaceuticals
Thyroid hormone medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Levothyroxine
Class of corticosteroids
Glucocorticoid receptor Immunosuppressive drug Membrane glucocorticoid receptor Metyrapone blocks glucocorticoid secretion Selective glucocorticoid receptor agonist
Glucocorticoid
Estrogen medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Ethinylestradiol
Antibiotic medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Rifampicin
Blood pressure medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Carvedilol
Flowering plant in the St John's wort family
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Hypericum_perforatum
Laxatives/stool softeners
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Docusate
Immunosuppressive drug
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Tacrolimus
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Cypermethrin
Antiretroviral medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Ritonavir
Antibiotic derived from Penicillin
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Flucloxacillin
Chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Fluticasone
Type of corticosteroid medication
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Budesonide
Class of chemical compounds
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Alkylbenzene_sulfonate
Medical condition
the adrenal gland by inhibiting 11-beta hydroxylase. Ketoconazole and metyrapone fall under this drug category. Besides mediating the function of adrenal
Adrenalism
Pharmaceutical drug
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Rimexolone
Class of steroid hormones
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Corticosteroid
Mineralocorticoid steroid hormone
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Aldosterone
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Dibunate
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Vinburnine
Group of stereoisomers
rogletimide (pyridoglutethimide) and thalidomide, as well as amphenone B, metyrapone, and mitotane. AG was introduced for medical use, as an anticonvulsant
Aminoglutethimide
Medication of the barbiturate type
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Phenobarbital
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Lipoic_acid
Antibiotic medication
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Rifaximin
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Mevastatin
Medication and naturally occurring steroid hormone
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Progesterone_(medication)
Antifungal chemical compound
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Ketoconazole
Chemical compound
LOE-908 Loratadine Lovastatin Meclizine Metacycline Methylprednisolone Metyrapone Mevastatin Mifepristone Nafcillin Nicardipine Nicotine Nifedipine Nilvadipine
Ciglitazone
Glucocorticoid steroid (chemical compound)
modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase
Betamethasone_dipropionate
travel, tourism, insurance
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
METYRAPONE
travel, tourism, insurance